Vaccination in the line of fire

References

• Bedford H, Elliman D. Concerns about immunisation. BM12000; 320: 240-243.
   Google Scholar
• Nokes DJ, Anderson RM. Vaccine safety versus vaccine efficacy in mass immunisation programmes. Lancet1991; 338: 1309–1312.
   Google Scholar
• Duclos P, Bentsi-Enchill A. Current thoughts on the risks and benefits of immunisation. Drug Sa11993; 8:404–413.
   Google Scholar
• Ali M, Emch M, Von Seidlein L, eta]. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet2005; 366: 44–49.
   Google Scholar
• Francois G, Duclos P, Margolis H, eta]. Vaccine safety controversies and the future of vaccination programs. Pediatr Infect Dis J2005; 24: 953–961.
   Google Scholar
• Gangarosa EJ, Galazka AM, Wolfe CR, eta]. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 1998; 351: 356–361.
   Google Scholar
• Breithaupt H, Gannon F, Hadley C. Degrees of risk. EMI30 Reports 2004; 5: S1–S3.
   Google Scholar
• Klein S. Alles Toeval Amsterdam: Ambo Anthos, 2005.
   Google Scholar
• Darwish AD. Presenting the case for an immunization safety surveillance system. Bull WildHlth 0rg2000; 78:216.
   Google Scholar
• Ward BJ. Vaccine adverse events in the new millennium: is there. reasonfor concern? Bull WildHlth 0rg2000; 78: 205–215.
   Google Scholar
• Davies P, Chapman S, Leask J. Antivaccination activists on the world wide web. ArchDis Child2002; 87:22–25.
   Google Scholar
• Wolfe RM, Sharp LK. Anti-vaccinationists past and present. BMJ 2002; 325:430–432.
   Google Scholar
• Centers for Disease Control and Prevention. Six common misconceptions about vaccination and how to respond to them. 2004. www.cdc.govinip/publications/6mishome.htm [Accessed February 2008]
   Google Scholar
• WHO. Six common misconceptions about immunization. World Health Organization. 2005. www.who.int/immunization safety/aefi/immunization misconceptio ns/en/print.html [Accessed February 20081.
   Google Scholar
• Ernst E. Rise in popularity of complementary and alternative medicine: reasons and consequences for vaccination. -1,hccine2001; 20\(Suppl 1): S90–S93.
   Google Scholar
• Atwood KC. Naturopathy: a critical appraisal. Medsc Gen Med2003; 5:4.
   Google Scholar
• Dittmann S. Vaccine safety: risk communication a global perspective. -1,hccine2001; 19:2446–2456.
   Google Scholar
• Ovetchkine P. Effets secondaires des vaccinations. Arch Pediatr2001; 8: 316–320.
   Google Scholar
• André FE. Vaccinology: past achievements, present roadblocks and future promises. -1,hccine2003; 21: 593–595.
   Google Scholar
• Ascherio A, Zhang SM, Hernán MA, eta]. Hepatitis B vaccination and the risk of multiple sclerosis. NEng1J Med2001; 344: 327–332.
   Google Scholar
• Confavreux C, Suissa S, Saddier P, Bourdes V, Vukusic S, for the Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. NEng1JMed2001; 344: 319–326.
   Google Scholar
• WHO. World Health Organization Global Advisory Committee on Vaccine Safety: Response to the paper by MA Hernán and others in Neurology 14th September 2004 issue entitled 'Recombinant Hepatitis B Vaccine and the Risk of Multiple Sclerosis.' Www.who.int/vaccine safety/topics/hepatitisb/multiple sclerosis/ sep-04/en/ [Accessed February 20081.
   Google Scholar
• GACVS. Global Advisory Committee on Vaccine Safety, 16–17 December 2002. WIdyEpidemio]Rec2003; 78: 17–20.
   Google Scholar
• GACVS. Global Advisory Committee on Vaccine Safety, 20–21 June 2002. WIdyEpidemiol Rec2002; 77: 389–394.
   Google Scholar
• Vaccine Safety Advisory Committee. Vaccine safety. Wldy Epidemiol Rec 1999; 74:337–340.
   Google Scholar
• Agence Franyaise de Sécurité Sanitaire des Produits de Santé (AFFSAPS). Conseil scientifique Séance du 05 mai 2004. Myofasciite macrophages. Secretariat des Conseils, No 2004–006.
   Google Scholar
• Wraight DC, Goldman M, Lambert P-H. Vaccination and autoimmune disease: what is the evidence?Lancet2003; 362: 1659–1666.
   Google Scholar
• Wakefield AJ, Murch SH, Anthony A, eta]. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet1998; 351:637-641 Vaccination in the line of fire.
   Google Scholar
• Murch SH, Anthony A, Casson DH, et al. Retraction of an interpretation. Lancet 2004; 363:750.
   Google Scholar
• Institute of Medicine. Immunization safety review: Vaccines and autism. 2004. books.nap.edu/catalog/10997.html [Accessed February 2008]
   Google Scholar
• WHO/UNICEF. Review of national immunization coverage 1980–2003 Sweden. August 2004.www.who.int/vaccines-surveillance/WHOUNICEF Coverage Review/pdf/sweden.pdf [Accessed F ebruary 2008]
   Google Scholar
• Andreae MC, Freed GL, Katz SL. Safety concerns regarding combination vaccines Perspective of select European countries. Human Ificcines2005;1: 1–5.
   Google Scholar
• May T, Silverman RD. Free-riding, fairness and the right of minority groups in exemption from mandatory childhood vaccination. Human Thccines2005; 1: 12–15.
   Google Scholar
• Ritvo P, Wilson K, Willms D, et a]., on behalf of the CANVAC Sociobehavioural Study Group. Vaccines in the public eye. Nat Med 2005; 11:20–S24.
   Google Scholar
• Hahné S, Macey J, Tipples G, et al. Rubella outbreak in an unvaccinated religious community in the Netherlands spreads to Canada. Euro Survel112005; 10:5.
   Google Scholar
• 36. Hahné S, Ward M, Abbink F, eta]. Large ongoing rubella outbreak in religious community in the Netherlands since September 2004. Euro Survei112005; 10:3.
   Google Scholar
• Jackson BM, Payton T, Horst G, Halpin TJ, Mortensen BK. An epidemiologic investigation of a rubella outbreak among the Amish of northeastern Ohio. Public Health Rep 1993; 108:436–439.
   Google Scholar
• Aston R. Scares, scams and sickness: countering the anti-vaccination lobby. Thccines: Children & Practice2002; 5:30–34.
   Google Scholar
• Centers for Disease Control and Prevention. Telebriefing transcript J.L. Gerberding - Media Briefing on Vaccines and Child Health. 2005. www.cdc.gov/od/oc/media/transcripts/t050719.htm [Accessed February 2008]
   Google Scholar
• Gellin BG, Schaffner W. The risk of vaccination the importance of 'negative' studies. NEng1JMed2001; 344:372–373.
   Google Scholar
• Malhotra S, Shafiq N, Pandhi P. Advantages of reporting, publishing, and reading 'negative' studies. MedscPharmac2004; 5:2.
   Google Scholar
• Grabenstein JD, Wilson JP. Are vaccines safe? Risk communication applied to vaccination. Hospital Pharmacy1999; 34:713–729.
   Google Scholar
• Connolly T, Reb J. Omission bias in vaccination decisions: Where's the 'omission'? Where's the 'bias'? Organ Behav Hum Decis Proc 2003;91: 186–202.
   Google Scholar
• Shaw GB. The doctor's dilemma. IntJEpidemio12003; 32:910–915.
   Google Scholar
• Barale A. The Cochrane Vaccines Field. Uccine2004; 22: 2044–2045.
   Google Scholar